News & Innovation

Tackling cancer at the time of COVID-19 – The Time to Act is Now!

July 15, 2021

Though the COVID-19 pandemic has halted, altered and/or delayed oncology treatment for many patients, cancer isn’t waiting for normality to resume.

The European Cancer Organisation (ECO), with the support of BD, has launched the TIME TO ACT campaign to urgently address the impact that COVID-19 has had on cancer care. 

The TIME TO ACT campaign kicked off on May 11th with an online event, where regional healthcare leaders and policymakers came together to confront the challenges of COVID-19 and discuss what actions to take to reinstate and improve cancer care during the pandemic. 

With this initiative, the ECO encourages the action and support needed for healthcare organisations to allow more cancer patients in hospitals and clinics safely and efficiently, addressing the current gaps and delays in oncology care as well as the growing patient backlog.

COVID-19 and cancer in Europe, by the numbers:1

  • 1.5 million fewer cancer patients visited their clinicians in the first year of the pandemic
  • 1 million European cancer cases may be going undetected due to the global pandemic
  • 1 in 5 cancer patients are not receiving necessary surgical or chemotherapy treatment due to COVID-19 (In 2020, these treatment delays affected 1 in every 2 patients) 
  • 100 million screening tests were not performed during the pandemic, contributing to the estimated 100,000 cancer patients added to the backlog every month, which could take at least one year to clear
  • 4 in 10 healthcare workers are feeling burnout and 3 in 10 report signs of clinical depression

BD proudly supports the ECO and the TIME TO ACT campaign, encouraging and participating in the fight against cancer. 

Everyone has a role to play. To learn more about the campaign and how you can support better cancer care during the pandemic,


#COVID-19 #European Cancer Organisation #Time to Act Campaign


  1. Covid-19 & Cancer Data Intelligence. Time To Act. European Cancer Organisation (ECO). Published 2021. Accessed May 21, 2021. 

This list of references to third-party peer-reviewed material and the sites they are hosted on are provided for your reference and convenience only, and do not imply any review or endorsement of the material or any association with their operators.  The Third-Party References (and the Web sites to which they link) may contain information that is inaccurate, incomplete, or outdated. Your access and use of the Third Party Sites (and any Web sites to which they link) is solely at your own risk.

Approval number: BD-35918.